Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Chinese journal of integrative medicine ; (12): 98-104, 2017.
Article in English | WPRIM | ID: wpr-327208

ABSTRACT

<p><b>OBJECTIVE</b>To observe the efficacy and safety of the Chinese medicine (CM) Compound Zhuye Shigao Granule (, CZSG) on acute radiation-induced esophagitis (ARIE) in cancer patients.</p><p><b>METHODS</b>In a blinded, randomized, Kangfuxin Solution (, KFX)-controlled, single-centre clinical trial, 120 patients with lung, esophagus or mediastinal cancer were prospectively enrolled and assigned to the treatment group (60 cases) and control group (60 cases) by the random number table method. All patients received concurrent or sequential radiotherapy (2 Gy per day, 5 times per week, for 4 weeks) and were treated for 4 weeks since the radiation therapy. Patients in the treatment group were given 12 mg CZSG orally, thrice daily, while patients in the control group were given 10 mL KFX orally, thrice daily. The major indicators were observed, including the incidence and grade of esophagitis, time of occurrence and duration. Minor indicators were changes of CM symptoms, weight and Karnofsky Performance Status (KPS) Scale during 4 weeks from the beginning, recorded once a week. Blood routine examination and hepatorenal function were detected at the 2nd and 4th weeks.</p><p><b>RESULTS</b>The incidence and grade of ARIE were significantly decreased in the treatment group compared with the control group (P<0.05). CZSG appeared to significantly delay the time of ARIE occurrence and reduce the duration compared with KFX (P<0.05). The scores of CM symptoms, KPS and weight were improved significantly in the treatment group compared with the control group (P<0.05). There were no blood routine and hepatorenal function abnormal or obvious side-effects in both groups. Hemoglobin was improved and neutrophil and interleukin 6 were decreased in both groups after 4-week treatment compared with before treatment (P<0.05), and there was no significant difference between the two groups (P>0.05).</p><p><b>CONCLUSIONS</b>CZSG can decrease the incidence and grade of ARIE, delay the time of occurrence, reduce duration and alleviate the damage of ARIE. It is safe and effective in the prevention and cure of ARIE.</p>


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Acute Disease , Drugs, Chinese Herbal , Esophagitis , Drug Therapy , Medicine, Chinese Traditional , Methods , Neoplasms , Drug Therapy , Radiotherapy , Radiation Injuries , Drug Therapy , Radiotherapy Dosage , Treatment Outcome
2.
Chinese journal of integrative medicine ; (12): 462-467, 2014.
Article in English | WPRIM | ID: wpr-262642

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of Modified Zhuye Shigao Decoction (MZSD) and its components on preventing radiation esophagitis of rats.</p><p><b>METHODS</b>One hundred Wistar rats were randomly divided into 5 groups, including the control group, radiation model group, MZSD group, Zhuye Shigao Decoction (ZSD) group, and added ingredients group, 20 rats in each group. The model of radiation esophagitis of rat was established by once local radiation of 40 Gy (330 Mu/min) with a high energy linear accelerator. The administration of Chinese medicine was continued for 14 days from 7 days before radiation application in the three treatment groups. On the 7th and 14th day, the serum was isolated and the levels of inflammatory cytokines tumor necrosis factor (TNF-α), interleukin 1β (IL-1β) and IL-8 were tested. The pathological slices of esophagus were obtained, and the pathological changes were observed. During the whole process, weight and food intake were recorded each day.</p><p><b>RESULTS</b>On the 7th day after radiation, the esophagus of rats in the MZSD group was almost intact, and the pathological injury score was significantly lower than that of the radiation model group, ZSD group and added ingredients group (P<0.01). Compared with the control group, the body weight and food intake of rats in the radiation model group were significantly decreased, and the levels of TNF-α, IL-1β and IL-8 were significantly increased (P<0.05 or P<0.01), while the MZSD group showed a significant increase in body weight and food intake, and a significant decrease in the levels of TNF-α, IL-1β and IL-8 compared with the radiation model group, ZSD group and added ingredients group (P <0.05 or P<0.01).</p><p><b>CONCLUSION</b>MZSD prevents the development of radiation esophagitis probably by inhibiting the generation and release of the inflammatory cytokines TNF-α, IL-1β and IL-8.</p>


Subject(s)
Animals , Male , Body Weight , Cytokines , Metabolism , Drugs, Chinese Herbal , Pharmacology , Therapeutic Uses , Esophagitis , Drug Therapy , Pathology , Esophagus , Pathology , Feeding Behavior , Inflammation Mediators , Metabolism , Neutrophil Infiltration , Radiation Injuries , Drug Therapy , Pathology , Rats, Wistar , Time Factors
3.
Journal of Southern Medical University ; (12): 760-762, 2010.
Article in Chinese | WPRIM | ID: wpr-355025

ABSTRACT

<p><b>OBJECTIVE</b>To study the effect of Kidney-Tonifying plus Blood-Promoting Recipe on the expression of CD11b/CD18 and Bcl-2/Bax in elderly patients with kidney deficiency and blood stasis syndrome.</p><p><b>METHODS</b>Sixty elderly patients with kidney deficiency and blood stasis syndrome were randomized into two groups. Patients in the treatment group received Kidney-Tonifying plus Blood-Promoting Recipe, and those in the control group receive no treatment. The expression of CD11b/CD18, Bcl-2/Bax, D-Dimeride, CD62p, PAC-I and the rate of platelet aggregation in peripheral blood leukocytes before and after the treatment were examined using flow cytometry in both groups.</p><p><b>RESULTS</b>The Recipe significantly decreased the levels of CD11b/CD18, D-Dimeride, CD62p, PAC-I and the rate of platelet aggregation (P<0.01), and increased the levels of Bcl-2/Bax (P<0.01).</p><p><b>CONCLUSION</b>Kidney-Tonifying plus Blood-Promoting Recipe regulates CD11b/CD18 and Bcl-2/Bax expression in blood leukocytes and improves microcirculatory status, which can be one of the mechanisms underlying its therapeutic effect in elderly patients.</p>


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Aging , CD11b Antigen , Blood , CD18 Antigens , Blood , Drugs, Chinese Herbal , Therapeutic Uses , Kidney Diseases , Drug Therapy , Metabolism , Leukocytes , Metabolism , Phytotherapy , Proto-Oncogene Proteins c-bcl-2 , Blood , bcl-2-Associated X Protein , Blood
SELECTION OF CITATIONS
SEARCH DETAIL